Synairgen Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Synairgen Stock Forecast and Price Target
Synairgen's stock is projected to advance by 566.67% from the previous closing price if it reaches the average target of £0.40 by the year's end, as reputable analysts recently projected. This potential upside is calculated on a high-end estimate of £0.40 and a low-end estimate of £0.40. If you're thinking of investing in SNG stock, it might be good to look at its rivals too.
566.67% Upside
Synairgen Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Synairgen's Price has seen an increase, rising from £0.00 to £0.00. This represents a growth of 100.00%. Analysts predict that Synairgen's Fair Value will increase in the upcoming year, reaching £0.06. This would represent an increase of 100.00%. Over the next seven years, experts predict that Synairgen's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GWPH Stock Forecast | GW Pharmaceuticals | - |
6
|
$219.00 | Buy/Sell | $188.33 | 5.14% |
| ABCM Stock Forecast | Abcam | - |
18
|
$23.99 | Buy/Sell | $19.25 | -67.15% |
| GNS Stock Forecast | Genus | Buy |
18
|
£17.36 | Buy/Sell | £33.09 | 58.41% |
| SLN Stock Forecast | Silence Therapeutics | Outperform |
7
|
$21.42 | Buy/Sell | $42.75 | 133.43% |
| BCYC Stock Forecast | Bicycle Therapeutics | Outperform |
7
|
$24.20 | Buy/Sell | $44.47 | 77.69% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AUTL Stock Forecast | Autolus Therapeutics | Buy |
6
|
$4.00 | Buy/Sell | $9.23 | 175.00% |
| CMPS Stock Forecast | COMPASS Pathways | Buy |
3
|
$8.48 | Buy/Sell | $45.43 | 224.29% |
| MREO Stock Forecast | Mereo BioPharma Group | Buy |
5
|
$3.15 | Buy/Sell | $3.46 | 51.43% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ORTX Stock Forecast | Orchard Therapeutics | - |
7
|
$16.70 | Buy/Sell | $16.00 | -100.00% |
| NIOX Stock Forecast | NIOX Group Plc | Buy |
6
|
£0.70 | Buy/Sell | £0.76 | 10.00% |
| OXB Stock Forecast | Oxford Biomedica | Outperform |
10
|
£2.87 | Buy/Sell | £4.24 | 36.93% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ADAP Stock Forecast | Adaptimmune Therapeutics | Outperform |
7
|
$1.21 | Buy/Sell | $3.60 | 106.61% |
| BVXP Stock Forecast | Bioventix PLC |
18
|
£43.25 | Buy/Sell | £44.00 | 36.42% | |
| HZD Stock Forecast | Horizon Discovery Group | - |
3
|
£0.00 | Buy/Sell | £0.00 | 0.00% |
Synairgen EBITDA Forecast for 2023 - 2025 - 2030
Synairgen's EBITDA has grown in the last two years, jumping from £-17.64M to £-20.20M – an increase of 14.51%. According to 1 prominent analysts, Synairgen's EBITDA will fall by 66.34% in the next year, reaching £-6.80M. For the next seven years, the forecast is for EBITDA to grow by 26.93%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ETX Stock Forecast | e-therapeutics |
9
|
£0.16 | Buy/Sell | £0.16 | -100.00% | |
| AGY Stock Forecast | Allergy Therapeutics | - |
12
|
£0.03 | Buy/Sell | £0.50 | -100.00% |
| SCLP Stock Forecast | Scancell Holdings | Buy |
4
|
£0.09 | Buy/Sell | £0.23 | 155.56% |
Synairgen EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Synairgen's EBIT has increased by 14.43%, going from £-17.74M to £-20.30M. In the following year, 1 experts forecast Synairgen's EBIT will decrease by 65.52%, to £-7.00M. The Synairgen forecast is for EBIT to reach £-25.59M or grow by 26.07%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BRNS Stock Forecast | Barinthus Biotherapeutics | Outperform |
2
|
$2.20 | Buy/Sell | $8.80 | 218.18% |
| REDX Stock Forecast | Redx Pharma Plc | Buy |
9
|
£0.15 | Buy/Sell | £1.25 | 766.67% |
| DDDD Stock Forecast | 4D pharma | - |
7
|
£0.36 | Buy/Sell | £0.00 | -100.00% |
Synairgen EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Synairgen's EPS has seen an increase, rising from £-0.09 to £0.00. This represents a growth of 100.00%. Analysts predict that Synairgen's EPS will increase in the upcoming year, reaching £-0.03. This would represent an increase of 100.00%. Over the next seven years, experts predict that Synairgen's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NANO Stock Forecast | Nanoco Group |
8
|
£0.19 | Buy/Sell | £0.09 | 215.79% | |
| TLSA Stock Forecast | Tiziana Life Sciences Ltd | Buy |
2
|
$0.52 | Buy/Sell | $5.00 | 363.46% |
| DNL Stock Forecast | Diurnal Group | - |
0
|
£0.27 | Buy/Sell | £0.69 | -100.00% |
.jpg)